Georgia Gomatou

852 total citations
33 papers, 522 citations indexed

About

Georgia Gomatou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Georgia Gomatou has authored 33 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Georgia Gomatou's work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related Molecular Pathways (4 papers) and Immunotherapy and Immune Responses (3 papers). Georgia Gomatou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cancer-related Molecular Pathways (4 papers) and Immunotherapy and Immune Responses (3 papers). Georgia Gomatou collaborates with scholars based in Greece, United States and Kuwait. Georgia Gomatou's co-authors include Ηλίας Κοττέας, Nikolaos Syrigos, Vasilios Tzilas, Demosthenes Bouros, Ioannis P. Trontzas, Evangelos Bouros, Rodoula Trigidou, Αrgyris Τzouvelekis, Ioannis Vathiotis and Konstantinos Syrigos and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and CHEST Journal.

In The Last Decade

Georgia Gomatou

33 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georgia Gomatou Greece 11 270 260 161 75 47 33 522
Shinichiro Shimamatsu Japan 12 277 1.0× 352 1.4× 175 1.1× 89 1.2× 92 2.0× 40 580
Betsy Morrow United States 11 211 0.8× 180 0.7× 122 0.8× 41 0.5× 56 1.2× 18 497
Kyrillus S. Shohdy Egypt 12 213 0.8× 197 0.8× 88 0.5× 114 1.5× 26 0.6× 39 440
Feifei Na China 14 224 0.8× 166 0.6× 210 1.3× 111 1.5× 114 2.4× 33 618
Gemma Toledo Spain 12 173 0.6× 187 0.7× 324 2.0× 78 1.0× 50 1.1× 22 637
Giorgia Guaitoli Italy 12 162 0.6× 229 0.9× 146 0.9× 121 1.6× 33 0.7× 27 436
Hiroto Kishi Japan 10 145 0.5× 245 0.9× 208 1.3× 38 0.5× 23 0.5× 21 435
Tommasina Biscotti Italy 13 233 0.9× 430 1.7× 182 1.1× 208 2.8× 59 1.3× 21 690
Mami Inayama Japan 7 290 1.1× 107 0.4× 112 0.7× 45 0.6× 54 1.1× 18 474

Countries citing papers authored by Georgia Gomatou

Since Specialization
Citations

This map shows the geographic impact of Georgia Gomatou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia Gomatou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia Gomatou more than expected).

Fields of papers citing papers by Georgia Gomatou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia Gomatou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia Gomatou. The network helps show where Georgia Gomatou may publish in the future.

Co-authorship network of co-authors of Georgia Gomatou

This figure shows the co-authorship network connecting the top 25 collaborators of Georgia Gomatou. A scholar is included among the top collaborators of Georgia Gomatou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgia Gomatou. Georgia Gomatou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomatou, Georgia, et al.. (2024). CAR-T Cell Therapy in Pancreatic and Biliary Tract Cancers: An Updated Review of Clinical Trials. Journal of Gastrointestinal Cancer. 55(3). 990–1003. 5 indexed citations
2.
Lanitis, Sophocles, et al.. (2024). Mutations Matter: Unravelling the Genetic Blueprint of Invasive Lobular Carcinoma for Progression Insights and Treatment Strategies. Cancers. 16(22). 3826–3826. 2 indexed citations
3.
Gomatou, Georgia, Andriani Charpidou, Peifeng Li, Nikolaos Syrigos, & Ioannis Gkiozos. (2024). Mechanisms of primary resistance to immune checkpoint inhibitors in NSCLC. Clinical & Translational Oncology. 27(4). 1426–1437. 2 indexed citations
4.
Fiste, Oraianthi, et al.. (2024). Inflammation-related biomarkers as predictors of pathological complete response in early-stage breast cancer. Clinical & Translational Oncology. 27(6). 2453–2460. 1 indexed citations
5.
Gomatou, Georgia, et al.. (2023). Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives. Current Oncology. 30(11). 9734–9745. 9 indexed citations
6.
Gomatou, Georgia, et al.. (2023). Lung microbiome: an emerging player in lung cancer pathogenesis and progression. Clinical & Translational Oncology. 25(8). 2365–2372. 13 indexed citations
7.
Gomatou, Georgia, et al.. (2023). The Role of REV-ERB Receptors in Cancer Pathogenesis. International Journal of Molecular Sciences. 24(10). 8980–8980. 7 indexed citations
8.
Gomatou, Georgia, Nikolaos Syrigos, & Ηλίας Κοττέας. (2023). Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options. Cancers. 15(3). 841–841. 77 indexed citations
9.
Vasilakaki, Sofia, et al.. (2023). Molecular Interactions of Antibodies with PD-1/PD-L1 Proteins. Immunotherapy. 16(1). 21–28. 1 indexed citations
10.
Syrigos, Nikolaos, et al.. (2023). Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC. Cancers. 15(23). 5589–5589. 13 indexed citations
11.
Trontzas, Ioannis P., et al.. (2022). Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives. Clinical Breast Cancer. 22(7). 642–649. 7 indexed citations
12.
Dimakakos, Evangelos, Georgia Gomatou, M. Catalano, et al.. (2022). Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art. Anticancer Research. 42(7). 3261–3274. 6 indexed citations
13.
Gomatou, Georgia, et al.. (2022). BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it. Clinical & Translational Oncology. 25(1). 10–20. 17 indexed citations
14.
Trontzas, Ioannis P., Vasiliki Rapti, Nikolaos Syrigos, et al.. (2022). Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation. Journal of Chemotherapy. 35(1). 63–71. 6 indexed citations
15.
Gomatou, Georgia, et al.. (2021). Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors. Molecular Biology Reports. 48(1). 915–925. 27 indexed citations
16.
Gomatou, Georgia, et al.. (2021). Pulmonary Blastoma: A Comprehensive Overview of A Rare Entity. Advances in respiratory medicine. 89(5). 511–519. 4 indexed citations
17.
Dimakakos, Evangelos, Ioannis Vathiotis, Georgia Gomatou, et al.. (2021). Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer. Anticancer Research. 41(3). 1523–1528. 4 indexed citations
18.
Τzouvelekis, Αrgyris, Georgia Gomatou, Evangelos Bouros, et al.. (2019). Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer. CHEST Journal. 156(2). 383–391. 108 indexed citations
19.
Gomatou, Georgia, et al.. (2019). Pulmonary nocardiosis associated with Cushing's disease: a case report. Monaldi Archives for Chest Disease. 89(3). 3 indexed citations
20.
Gomatou, Georgia, et al.. (2018). Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: A case report. Respiratory Medicine Case Reports. 25. 253–256. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinichiro Shimamatsu Breakdown of academic impact, for papers by Betsy Morrow Breakdown of academic impact, for papers by Kyrillus S. Shohdy Breakdown of academic impact, for papers by Feifei Na Breakdown of academic impact, for papers by Gemma Toledo Breakdown of academic impact, for papers by Giorgia Guaitoli Breakdown of academic impact, for papers by Hiroto Kishi Breakdown of academic impact, for papers by Tommasina Biscotti Breakdown of academic impact, for papers by Mami Inayama
Rankless by CCL
2026